JPH2 may serve as a marker for UPS, as it was previously reported to be overexpressed in leiomyosarcomas compared to an endometrial stromal sarcoma (Davidson et al., 2013). This evidence concerns the gene JPH2 and endometrioid stromal sarcoma.